Coronavirus and Venture Capital

Despite a research focus completely unrelated to COVID-19, Camarillo’s ImmPACT Bio managed to accomplish something unusual: It garnered $18 million when its Series A funding round closed in August...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

• 26 biweekly issues
• Subscriber-only digital content for prime stories
• Book of Lists — the most comprehensive business resource in the Valley region

Yours for only $49

First name:

Last name:

Email:

Address:

Zip:

CC Number:

Cvv:

Exp Month:

Exp Year: